Patents Assigned to Cytlmmune Sciences, Inc.
  • Publication number: 20150018486
    Abstract: The present invention comprises compositions and methods for delivery systems of agents, including therapeutic compounds, pharmaceutical agents, drugs, detection agents, nucleic acid sequences and biological factors. In general, the nanotherapeutic compositions of the present invention comprise a platform comprising a colloidal metal, a targeting ligand such a tumor necrosis factor, a stealth agent such as polyethylene glycol, and one or more diagnostic or therapeutic agents for delivery. The invention also comprises methods and compositions for making such nanotherapeutic compositions and for the treatment of cancer.
    Type: Application
    Filed: February 14, 2014
    Publication date: January 15, 2015
    Applicant: Cytlmmune Sciences, Inc.
    Inventors: Lawrence Tamarkin, Giulio F. Paciotti, Marja S. Huhta
  • Patent number: 8486663
    Abstract: The compositions and methods of the present invention comprise the efficient and effective presentation of antigens to the appropriate components of the immune system resulting in the production of species-specific antibodies in vitro. In general, these compositions comprise one or more antigenic components together with a colloidal metal, optionally combined with derivatized PEG (polyethylene glycol) or other agents. The invention also comprises methods and compositions for making such colloidal metal compositions.
    Type: Grant
    Filed: May 12, 2011
    Date of Patent: July 16, 2013
    Assignee: Cytlmmune Sciences, Inc.
    Inventors: Giulio F. Paciotti, Ramadevi Raghunandan, Marja S. Huhta, Lawrence Tamarkin